Structural changes in the airways in asthma: Observations and consequences

Clinical Science

Volumn 108, Issue 6, 2005, Pages 463-477

  Bai, Tony R ^a   Knight, Darryl A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Airway smooth muscle; Asthma; Corticosteroid; Fibrosis; Lung function; Matrix; Remodelling

Indexed keywords

ANTIINFLAMMATORY AGENT; BECLOMETASONE DIPROPIONATE; BIGLYCAN; BRONCHODILATING AGENT; CORTICOSTEROID; DECORIN; ELASTIN; FLUTICASONE; INTERLEUKIN 13; MATRIX METALLOPROTEINASE; MUCIN; PLACEBO; PREDNISONE; PROSTAGLANDIN D2; PROSTANOID; TRANSFORMING GROWTH FACTOR BETA; TRIAMCINOLONE;

ADVENTITIA; AIRWAY OBSTRUCTION; AIRWAY RESISTANCE; APOPTOSIS; ASTHMA; BREATHING; BREATHING MUSCLE; BRONCHOSPASM; BRONCHUS BIOPSY; BRONCHUS MUCOSA; BRONCHUS MUCUS; CELL HYPERPLASIA; CELL INTERACTION; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DOSE RESPONSE; DRUG MEGADOSE; EXTRACELLULAR MATRIX; FORCED EXPIRATORY VOLUME; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GOBLET CELL; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; LOW DRUG DOSE; LUNG COMPLIANCE; LUNG FUNCTION; MORTALITY; MUCUS SECRETION; MUSCLE MASS; NERVE CELL PLASTICITY; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; REVIEW; SMOOTH MUSCLE FIBER; VITAL CAPACITY;

ADULT; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOCONSTRICTION; CHILD; HUMANS; LUNG; MUCUS; MUSCLE, SMOOTH; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MECHANICS; RESPIRATORY SYSTEM; SPUTUM;

EID: 20444462363     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20040342     Document Type: Review

References (155)

1. Evans, M., Van Winkle, L., Fanucchi, M. and Plopper, C. (1999) The attenuated fibroblast sheath of the respiratory tract epithelial-mesenchymal trophic unit. Am. J. Respir. Cell Mol. Biol. 21, 655-657
2. Laitinen, L. A., Heino, M., Laitinen, A., Kava, T. and Haahtela, T. (1985) Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am. Rev. Respir. Dis. 131, 599-606
3. Beasley, R., Roche, W. R., Roberts, J. A. and Holgate, S. T. (1989) Cellular events in the bronchi in mild asthma and after bronchial provocation. Am. Rev. Respir. Dis. 139, 806-817
4. Jeffery, P. K., Wardlaw, A. J., Nelson, F. C., Collins, J. V. and Kay, A. B. (1989) Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am. Rev. Respir. Dis. 140, 1745-1753
5. Vignola, A. M., Chanez, P., Campbell, A. M. et al. (1998) Airway inflammation in mild intermittent and in persistent asthma. Am. J. Respir. Crit. Care Med. 157, 403-409
6. Bousquet, J., Jeffery, P. K., Busse, W. W., Johnson, M. and Vignola, A. M. (2000) Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161, 1720-1745
7. Laitinen, L. A., Laitinen, A. and Haahtela, T. (1993) Airway mucosal inflammation even in patients with newly diagnosed asthma. Am. Rev. Respir. Dis. 147, 697-704
8. Benayoun, L., Druilhe, A., Dombret, M. C., Aubier, M. and Pretolani, M. (2003) Airway structural alterations selectively associated with severe asthma. Am. J. Respir. Crit. Care Med. 167, 1360-1368
9. Demoly, P., Simony-Lafontaine, J., Chanez, P. et al. (1994) Cell proliferation in the bronchial mucosa of asthmatics and chronic bronchitics. Am. J. Respir. Crit. Care Med. 150, 214-217
10. Montefort, S., Djukanovic, R., Holgate, S. T. and Roche, W. R. (1993) Ciliated cell damage in the bronchial epithelium of asthmatics and non-asthmatics. Clin. Exp. Allergy 23, 185-189
11. Ordonez, C., Ferrando, R., Hyde, D. M., Wong, H. H. and Fahy, J. V. (2000) Epithelial desquamation in asthma: artifact or pathology? Am. J. Respir. Crit. Care Med. 162, 2324-2329
12. Lackie, P. M., Baker, J. E., Gunthert, U. and Holgate, S. T. (1997) Expression of CD44 isoforms is increased in the airway epithelium of asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 16, 14-22
13. Puddicombe, S. M., Polosa, R., Richter, A. et al. (2000) Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J. 14, 1362-1374
14. Ordonez, C. L., Khashayar, R., Wong, H. H. et al. (2001) Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am. J. Respir. Crit Care Med. 163, 517-523
15. Groneberg, D. A., Eynott, P. R., Lim, S. et al. (2002) Expression of respiratory mucins in fatal status astnmaticus and mild asthma. Histopathology 40, 367-373
16. Carroll, N. G. (2002) Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax 57, 677-682
17. Payne, D. N., Rogers, A. V., Adelroth, E. et al. (2003) Early thickening of the reticular basement membrane in children with difficult asthma. Am. J. Respir. Crit. Care Med. 167, 78-82
18. Barbato, A., Turato, G., Baraldo, S. et al. (2003) Airway inflammation in childhood asthma. Am. J. Respir. Crit. Care Med. 168, 798-803
19. Chetta, A., Foresi, A., Del Donno, M., Bertorelli, G., Pesci, A. and Olivieri, D. (1997) Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 111, 852-857
20. Bai, T. R., Cooper, J., Koelmeyer, T., Pare, P. D. and Weir, T. (2000) The effect of age and duration of disease on airway structure in fatal asthma. Am. J. Respir. Crit. Care Med. 162, 663-669
21. Liesker, J. J. W., ten Hacken, N. H. T., Smith, M., Rutgers, S. R., Postmas, D. S. and Timmens, W. (2000) Airway basement membrane thickness is increased both in asthma and COPD. Eur. Respir. J. 16 (Suppl. 31), 72S
22. Kuwano, K., Bosken, C. H., Pare, P. D., Bai, T. R., Wiggs, B. R. and Hogg, J. C. (1993) Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 148, 1220-1225
23. Milanese, M., Crimi, E., Scordamaglia, A. et al. (2001) On the functional consequences of bronchial basement membrane thickening. J. Appl. Physiol. 91, 1035-1040
24. Brightling, C. B. C., Symon, F., Holgate, S., Wardlaw, A. and Pavord, I. (2002) Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346, 1699-1705
25. Huang, J., Olivenstein, R., Taha, R., Hamid, Q. and Ludwig, M. (1999) Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am. J. Respir. Crit. Care Med. 160, 725-729
26. Roberts, C. R. (1995) Is asthma a fibrotic disease? Chest 107, 111S-117S
27. Kinsella, M. G. (2004) The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Crit. Rev. Eukaryot. Gene Expr. 14, 203-234
28. Hirst, S. J., Martin, J., Bonacci, J. et al. (2004) Proliferative aspects of airway smooth muscle. J. Allergy Clin. Immunol. 114, S2-S17
29. Altraja, A., Virtanen, I., Kampe, M. et al. (1996) Expression of laminms in the airways in various types of asthmatic patients: a morphometric study. Am. J. Respir. Cell Mol. Biol. 15, 482-188
30. Haraguchi, M., Shimura, S. and Shirato, K. (1999) Morpnometric analysts of bronchial cartilage in chronic obstructive pulmonary disease and bronchial asthma. Am. J. Respir. Crit. Care Med. 159, 1005-1013
31. Bousquet, J., Lacoste, J. Y., Chanez, P., Vie, P., Godard, P. and Michel, F. B. (1996) Bronchial elastic fibers in normal subjects and asthmatic patients. Am. J. Respir. Crit. Care Med. 153, 1648-1654
32. Mauad, T., Xavier, A. C., Saldiva, P. H. and Dolhnikoff, M. (1999) Elastosis and fragmentation of fibers of the elastic system in fatal asthma. Am. J. Respir. Crit. Care Med. 160, 968-975
33. Mauad, T, Silva, L. F., Santos, M. A. et al. (2004) Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. Am. J. Respir. Crit. Care Med. 170, 857-862
34. Carroll, N. G., Perry, S., Karkhanis, A. et al. (2000) The airway longitudinal elastic fiber network and mucosal folding in patients with asthma. Am. J. Respir. Crit. Care Med. 161, 244-248
35. Ebina, M., Takahashi, T., Chiba, T. and Motomiya, M. (1993) Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am. Rev. Respir. Dis. 148, 720-726
36. Woodruff, P. G. (2004) Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. Am. J. Respir. Crit. Care Med. 169, 1001-1006
37. Baluk, P., Lee, C., Link, H. et al. (2004) Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways. Am. J. Pathol. 165, 1071-1085
38. Chetta, A., Zanini, A., Foresi, A. et al. (2003) Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone. Am. J. Respir. Crit Care Med. 167, 751-757
39. Carroll, N. G. (1997) Bronchial blood vessel dimensions in asthma. Am. J. Respir. Crit. Care Med. 155, 689-695
40. Carroll, N., Elliot, J., Morton, A. and James, A. (1993) The structure of large and small airways in nonfatal and fatal asthma. Am. Rev. Respir. Dis. 147, 405-410
41. Hogg, J. C. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 2645-2653
42. Yanai, M., Sekizawa, K., Ohrui, T., Sasaki, H. and Takishima, T. (1992) Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J. Appl. Physiol. 72, 1016-1023
43. King, G. G., Eberl, S., Salome, C. M., Young, I. H. and Woolcock, A. J. (1998) Differences in airway closure between normal and asthmatic subjects measured with single-photon emission computed tomography and technegas. Am. J. Respir. Crit. Care Med. 158, 1900-1906
44. Azzawi, M., Johnston, P. W., Majumdar, S., Kay, A. B. and Jeffery, P. K. (1992) T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am. Rev. Respir. Dis. 145, 1477-1482
45. Dunnill, M. S. (1960) The pathology of asthma, with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 13, 27-33
46. Dunnill, M. S., Massarella, G. R. and Anderson, J. A. (1969) A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax 24, 176-179
47. Faul, J. L., Tormey, V. J., Leonard, C. et al. (1997) Lung immunopathology in cases of sudden asthma death. Eur. Respir. J. 10, 301-307
48. Haley, K.J., Sunday, M. E., Wiggs, B. R. et al. (1998) Inflammatory cell distribution within and along asthmatic airways. Am. J. Respir. Crit. Care Med. 158, 565-572
49. Huber, H. I. and Koessler, K. K. (1922) The pathology of bronchial asthma. Arch. Intern. Med. 30, 689-760
50. Saetta, M., Di Stefano, A., Rosina, C., Thiene, G. and Fabbri, L. M. (1991) Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am. Rev. Respir. Dis. 143, 138-143
51. Sobonya, R. E. (1984) Quantitative structural alterations in long-standing allergic asthma. Am. Rev. Respir. Dis. 130, 289-292
52. Sur, S., Grotty, T. B., Kephart, G. M. et al. (1993) Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am. Rev. Respir. Dis. 148, 713-719
53. Synek, M., Beasley, R., Frew, A. J. et al. (1996) Cellular infiltration of the airways in asthma of varying severity. Am. J. Respir. Crit. Care Med. 154, 224-230
54. Hamid, Q., Song, Y., Kotsimbos, T. C. et al. (1997) Inflammation of small airways in asthma. J. Allergy Clin. Immunol. 100, 44-51
55. Carroll, N., Cooke, C. and James, A. (1997) The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. Eur. Respir. J. 10, 292-300
56. Balzar, S., Wenzel, S. E. and Chu, H. W. (2002) Transbronchial biopsy as a tool to evaluate small airways in asthma. Eur. Respir. J. 20, 254-259
57. Balzar, S., Chu, H., Strand, M. and Wenzel, S. (2004) Relationship of small airway chymase-positive mast cells and lung function in severe asthma, Am. J. Respir. Crit. Care Med., doi:10.1164/rccm.200407-949OC
58. Green, R. H., Brightling, C. E., Weltmann, G., Parker, D., Wardlaw, A. J. and Pavord, I. D. (2002) Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 57, 875-879
59. Frew, A. J., Chan, H., Lam, S. and Chan-Yeung, M. (1995) Bronchial inflammation in occupational asthma due to western red cedar. Am. J. Respir. Crit. Care Med. 151, 340-344
60. Amin, K., Ludviksdottir, D., Janson, C. et al. (2000) Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. Am. J. Respir. Crit. Care Med. 162, 2295-2301
61. Wenzel, S., Balzar, S., Cundall, M. and Chu, H. (2003) Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: Association with asthma severity, neutrophilic inflammation, and wound repair. J. Allergy Clin. Immunol. 111, 1345-1352
62. The ENFUMOSA Study Group (2003) The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur. Respir. J. 22, 470-477
63. Miranda, C., Busacker, A., Balzar, S., Trudeau, J. and Wenzel, S. E. (2004) Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J. Allergy Clin. Immunol. 113, 101-108
64. ten Brinke, A., Zwinderman, A. H., Sterk, P. J., Rabe, K. F. and Bel, E. H. (2004) 'Refractory' eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am. J. Respir. Crit. Care Med. 170, 601-605
65. van Diemen, C. C., Postma, D. S., Vonk, J. M., Bruinenberg, M., Scheuten, J. P. and Boezen, H. M (2005) Polymorphisms in the ADAM33 gene are associated with accelerated lung function decline in the general population. Am. J. Respir. Crit. Care Med. 171, A16
66. Jongepier, H., Boezen, H. M., Dijkstra, A. et al. (2004) Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma. Clin. Exp. Allergy 34, 757-760
67. Kay, A. B. (2004) A role for eosinophils in airway remodelling in asthma. Trends Immunol. 25, 477-482
68. Lee, J. J., Dimina, D., Macias, M. P. et al. (2004) Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305, 1773-1776
69. ten Brinke, A., Zwinderman, A. H., Sterk, P. J., Rabe, K. F. and Bel, E. H. (2001) Factors associated with persistent airflow limitation in severe asthma. Am. J. Respir. Crit. Care Med. 164, 744-748
70. Payne, D. N., Qiu, Y., Zhu, J. et al. (2004) Airway inflammation in children with difficult asthma: relationships with airflow limitation and persistent symptoms. Thorax 59, 862-869
71. van Rensen, E., Sont, J. K., Rabe, K. and Sterk, P. J. (2004) Mucosal CD4 and CD8 positive cells are associated with lung function decline after 7/8 years of follow-up in asthma patients. Eur. Respir. J. 23, 3348
72. 1-antitrypsin levels in adult asthmatics. Eur. Respir. J. 22, 795-801
73. Wang, R., Tai, H., Xie, C., Wane, X., Wright, J. and Churg, A. (2003) Cigarette smoke produces airway wall remodeling in rat tracheal explants. Am. J. Respir. Crit. Care Med. 168, 1232-1236
74. Tschumperlin, D. J., Shively, J. D., Kikuchi, T. and Drazen, J. M. (2003) Mechanical stress triggers selective release of fibrotic mediators from bronchial epithelium. Am. J. Respir. Cell Mol. Biol. 28, 142-149
75. Tschumperlin, D. J., Dai, G., MaIy, I. V. et al. (2004) Mechanotransduction through growth-factor shedding into the extracellular space. Nature (London) 429, 83-86
76. Choe, M. M., Sporn, P. H. and Swartz, M. A. (2003) An in vitro airway wall model of remodeling. Am. J. Physiol. Lung Cell. Mol. Physiol. 285, L427-L433
77. Martin, J. G. and Ramos-Barbon, D. (2003) Airway smooth muscle growth from the perspective of animal models. Respir. Physiol. 137, 251-261
78. Zhou, D., Zheng, X., Wang, L. et al. (2003) Expression and effects of cardiotrophin-1 (CT-I) in human airway smooth muscle cells. Br. J. Pharmacol. 140, 1237-1244
79. Zhou, L., Li, J., Goldsmith, A. et al. (2004) Human bronchial smooth muscle cell lines show a hypertrophic phenotype typical of severe asthma. Am. J. Respir. Crit. Care Med. 169, 703-711
80. Halayko, A. J., Kartha, S., Stelmack, G. L. et al. (2004) Phophatidylinositol-3 kinase/mammalian target of rapamycin/p70S6K regulates contractile protein accumulation in airway myocyte differentiation. Am. J. Respir. Cell Mol. Biol. 31, 266-275
81. Zheng, X., Zhou, D., Seow, C. Y. and Bai, T. R. (2004) Cardiotrophin-1 alters airway smooth muscle structure and mechanical properties in airway explants. Am. J. Physiol. Lung Cell. Mol. Physiol. 287, L1165-L1171
82. Schmidt, M., Sun, G., Stacey, M. A., Mori, L. and Mattoli, S. (2003) Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 171, 380-389
83. Tran, M. U., Weir, A. J., Fanucchi, M. V. et al. (2004) Smooth muscle hypertrophy in distal airways of sensitized infant rhesus monkeys exposed to house dust mite allergen. Clin. Exp. Allergy 34, 1627-1633
84. Haitchi, H. H., Powell, R. M., Holgate, S. T. and Davies, D. (2004) The influence of Th2 cytokines on ADAM33 and a smooth muscle actin (ASMA) expression in embryonic mouse lung explant cultures. Am. J. Respir. Crit. Care Med. 169, A546
85. Nakano, Y., Wong, J., de Jong, P. et al. (2005) The prediction of small airway dimensions using computed tomography. Am. J. Respir. Crit. Care Med. 171, 142-146
86. Kasahara, K., Shiba, K., Ozawa, T., Okuda, K. and Adachi, M. (2002) Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma. Thorax 57, 242-246
87. Niimi, A., Matsumoto, H., Amitani, R. et al. (2004) Effect of short-term treatment with inhaled corticosteroid on airway wall thickening in asthma. Am. J. Med. 116, 725-731
88. Niimi, A., Matsumoto, H., Takemura, M., Ueda, T, Chin, K. and Mishima, M. (2003) Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am. J. Respir. Crit. Care Med. 168, 983-988
89. Paganin, F., Seneterre, E., Chanez, P. et al. (1996) Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am. J. Respir. Crit. Care Med. 153, 110-114
90. Niimi, A., Matsumoto, H., Amitani, R. et al. (2000) Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices. Am. J. Respir. Crit. Care Med. 162, 1518-1523
91. Panhuysen, C. I., Bleecker, E. R., Koeter, G. H., Meyers, D. A. and Postma, D. S. (1998) Characterization of obstructive airway disease in family members of probands with asthma. An algorithm for the diagnosis of asthma. Am J. Respir. Crit. Care Med. 157, 1734-1742
92. Rijcken, B. and Weiss, S. (1996) Longitudinal analyses of airway responsiveness and pulmonary function decline. Am. J. Respir. Crit. Care Med. 154, S246-S249
93. Sears, M. R., Greene, J. M., Willan, A. R. et al. (2003) A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N. Engl. J. Med. 349, 1414-1422
94. Vonk, J. M., Jongepier, H., Panhuysen, C. I., Schouten, J. P., Bleecker, E. R. and Postma, D. S. (2003) Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 58, 322-327
95. Gronke, L., Kanniess, F., Holz, O., Jorres, R. A. and Magnussen, H. (2002) The relationship between airway hyper-responsiveness, markers of inflammation and lung function depends on the duration of the asthmatic disease. Clin. Exp. Allergy 32, 57-63
96. Boulet, L. (2003) Asymptomatic airway hyperresponsiveness: a curiosity or an opportunity to prevent asthma? Am. J. Respir. Crit. Care Med. 167, 371-378
97. Brusasco, V. and Pellegrino, R. (2003) Complexity of factors modulating airway narrowing in vivo: relevance to assessment of airway hyperresponsiveness. J. Appl. Physiol. 95, 1305-1313
98. Wagner, E. M., Liu, M. C., Weinmann, G. G., Permutt, S. and Bleecker, E. R. (1990) Peripheral lung resistance in normal and asthmatic subjects. Am. Rev. Respir. Dis. 141, 584-588
99. Wagner, E. M., Bleecker, E. R., Permutt, S. and Liu, M. C. (1998) Direct assessment of small airways reactivity in human subjects. Am. J. Respir. Crit. Care Med. 157, 447-452
100. Kaminsky, D. A., Wenzel, S. E., Carcano, C., Gurka, D., Feldsien, D. and Irvin, C. G. (1997) Hyperpnea-induced changes in parenchymal lung mechanics in normal subjects and in asthmatics. Am. J. Respir. Crit. Care Med. 155, 1260-1266
101. Lambert, R. K., Wiggs, B. R., Kuwano, K., Hogg, J. C. and Pare, P. D. (1993) Functional significance of increased airway smooth muscle in asthma and COPD. J. Appl. Physiol. 74, 2771-2781
102. Wagers, S., Lundblad, L. K., Ekman, M., Irvin, C. G. and Bates, J. H. (2004) The allergic mouse model of asthma: normal smooth muscle in an abnormal lung? J. Appl. Physiol. 96, 2019-2027
103. Wagers, S. S., Norton, R. J., Rinaldi, L. M., Bates, J. H., Sobel, B. E. and Irvin, C. G. (2004) Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness. J. Clin. Invest. 114, 104-111
104. Duguet, A., Biyah, K., Minshall, E. et al. (2000) Bronchial responsiveness among inbred mouse strains. Role of airway smooth-muscle shortening velocity. Am. J. Respir. Crit. Care Med. 161, 839-848
105. Salome, C. M., Thorpe, C. W, Diba, C., Brown, N. J., Berend, N. and King, G. G. (2003) Airway re-narrowing following deep inspiration in asthmatic and nonasthmatic subjects. Eur. Respir. J. 22, 62-68
106. Gillis, H. L. and Lutchen, K. R. (1999) Airway remodeling in asthma amplifies heterogeneities in smooth muscle shortening causing hyperresponsiveness. J. Appl. Physiol. 86, 2001-2012
107. Lutchen, K. R., Jensen, A., Atileh, H. et al. (2001) Airway constriction pattern is a central component of asthma severity: the role of deep inspirations. Am. J. Respir. Crit. Care Med. 164, 207-215
108. Hoshino, M., Nakamura, Y. and Sim, J. J. (1998) Expression of growth factors and remodelling of the airway wall in bronchial asthma. Thorax 53, 21-27
109. James, A. L., Maxwell, P. S., Pearce-Pinto, G., Elliot, J. G. and Carroll, N. G. (2002) The relationship of reticular basement membrane thickness to airway wall remodeling in asthma. Am. J. Respir. Crit. Care Med. 166, 1590-1595
110. McParland, B., Macklem, P. and Pare, P. (2003) Airway wall remodeling: friend or foe? J. Appl. Physiol. 95, 426-434
111. Bai, T. R., Bates, J. H., Brusasco, V. et al. (2004) On the terminology for describing the length-force relationship and its changes in airway smooth muscle. J. Appl. Physiol. 97, 2029-2034
112. Slats, A. M., de Kluijver, J., Evertse, C. E., Sont, J. K., Mauad, T., Rabe, K. F. and Sterk, P. J. (2004) Bronchodilatory effect of deep inspiration and extracellular matrix composition of the airways in asthma. Am. J. Respir. Crit. Care Med. 169, A248
113. Westergren-Thorsson, G. (2002) Correlation between airway responsiveness and proteoglycan production by bronchial fibroblasts from normal and asthmatic subjects. Int. J. Biochem. 34, 1256-1267
114. Bai, T. R. (1990) Abnormalities in airway smooth muscle in fatal asthma. Am. Rev. Respir. Dis. 141, 552-557
115. Ma, X., Cheng, Z., Kong, H. et al. (2002) Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects. Am. J. Physiol. Lung Cell. Mol. Physiol. 283, L1181-L1189
116. Turner, D. J., Noble, P. B., Lucas, M. P. and Mitchell, H. W. (2002) Decreased airway narrowing and smooth muscle contraction in hyperresponsive pigs. J. Appl. Physiol. 93, 1296-1300
117. Vanacker, N. J., Palmans, E., Kips, J. C. and Pauwels, R. A. (2001) Fluticasone inhibits but does not reverse allergen-induced structural airway changes. Am. J. Respir. Crit. Care Med. 163, 674-679
118. Pitchford, S. and Page, C. (2003) Extracellular matrix composition influences the resistance of airway remodelling events towards glucocorticoid treatment. Br. J. Pharmacol. 138, 1181-1182
119. Wilson, J. W., Li, X. and Pain, M. C. (1993) The lack of distensibility of asthmatic airways. Am. Rev. Respir. Dis. 148, 806-809
120. Ward, C., Johns, D. P., Bish, R. et al. (2001) Reduced airway distensibility, fixed airflow limitation, and airway wall remodeling in asthma. Am. J. Respir. Crit. Care Med. 164, 1718-1721
121. Brackel, H. J., Pedersen, O. F., Mulder, P. G., Overbeek, S. E., Kerrebijn, K. F. and Bogaard, J. M. (2000) Central airways behave more stiffly during forced expiration in patients with asthma. Am. J. Respir. Crit. Care Med. 162, 896-904
122. Colebatch, H. J., Finucane, K. E. and Smith, M. M. (1973) Pulmonary conductance and elastic recoil relationships in asthma and emphysema. J. Appl. Physiol. 34, 143-153
123. Gelb, A. F., Schein, A., Nussbaum, E. et al. (2004) Risk factors for near-fatal asthma. Chest 126, 1138-1146
124. in 't Veen, J. C., Beekman, A. J., Bel, E. H. and Sterk, P. J. (2000) Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am. J. Respir. Crit. Care Med. 161, 1902-1906
125. Kuyper, L. M., Pare, P. D., Hogg, J. C. et al. (2003) Characterization of airway plugging in fatal asthma. Am. J. Med. 115, 6-11
126. Brown, R. H., Mitzner, W. and Wagner, E. M. (1997) Interaction between airway edema and lung inflation on responsiveness of individual airways in vivo. J. Appl. Physiol. 83, 366-370
127. Merkus, P. J., van Pelt, W., van Houwelingen, J. C. et al. (2004) Inhaled corticosteroids and growth of airway function in asthmatic children. Eur. Respir. J. 23, 861-868
128. Xuan, W., Marks, G. B., Toelle, B. G. et al. (2002) Risk factors for onset and remission of atopy, wheeze, and airway hyperresponsiveness. Thorax 57, 104-109
129. Phelan, P. D., Robertson, C. and Olinsky, A. (2002) The Melbourne Asthma Study: 1964-1999. J. Allergy Clin. Immunol. 109, 189-194
130. Vonk, J. M., Postma, D. S., Boezen, H. M. et al. (2004) Childhood factors associated with asthma remission after 30 year follow up. Thorax 59, 925-929
131. Rasmussen, F., Taylor, D. R., Flannery, E. M. et al. (2002) Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood. Am. J. Respir. Crit. Care Med. 165, 1480-1488
132. Gilliland, F., Berhane, K., Li, Y., Rappaport, E. and Peters, J. (2003) Effects of early onset asthma and in utero exposure to maternal smoking on childhood lung function. Am. J. Respir. Crit. Care Med. 167, 917-924
133. Zeiger, R. S. and Dawson, C. W. S. (1999) Relationships between duration of asthma and asthma seventy among children in the Childhood Asthma Management Program (CAMP). J. Allergy Clin. Immunol. 103, 376-387
134. Covar, R. A., Spahn, J. D., Murphy, J. R. et al. (2004) Progression of asthma measured by lung function in the childhood asthma management program. Am. J. Respir. Crit. Care Med. 170, 234-241
135. Agertoft, L. and Pedersen, S. (1994) Effects of lone-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir. Med. 88, 373-381
136. Grol, M. H., Gerritsen, J., Vonk, J. M. et al. (1999) Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. Am. J. Respir. Crit. Care Med. 160, 1830-1837
137. Martinez, F., Wright, A., Taussig, L. et al. (1995) Asthma and wheezing in the first six years of life. N. Engl. J. Med. 332, 133-138
138. Palmer, L. J., Rye, P. J., Gibson, N. A., Burton, P. R., Landau, L. I. and Lesouef, P. N. (2001) Airway responsiveness in early infancy predicts asthma, lung function, and respiratory symptoms by school age. Am. J. Respir. Crit. Care Med. 163, 37-42
139. Apostol, G. G., Jacobs, Jr, D. R., Tsai, A. W. et al. (2002) Early life factors contribute to the decrease in lung function between ages 18 and 40: the Coronary Artery Risk Development in Young Adults study. Am. J. Respir. Crit. Care Med. 166, 166-172
140. James, A., Palmer, L., Kicic, E. et al. (2005) Decline in lung function in the Busselton health study: the effects of asthma and cigarette smoking. Am. J. Respir. Crit. Care Med. 171, 109-114
141. Lange, P., Parner, J., Vestbo, J., Schnohr, P. and Jensen, G. (1998) A 15-year follow-up study of ventilatory function in adults with asthma. N. Engl. J. Med. 339, 1194-1200
142. Ulrik, C. S. and Backer, V. (1999) Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur. Respir. J. 14, 892-896
143. Sherrill, D., Guerra, S., Bobadilla, A. and Barbee, R. (2003) The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics. Eur. Respir. J. 21, 95-10
144. Ulrik, C. S. and Lange, P. (1994) Decline of lung function in adults with bronchial asthma. Am. J. Respir. Crit. Care Med. 150, 629-634
145. Bumbacea, D., Campbell, D., Nguyen, L. et al. (2004) Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur. Respir. J. 24, 122-128
146. Oshita, Y., Koga, T., Kamimura, T., Matsuo, K., Rikimaru, T. and Aizawa, H. (2003) Increased circulating 92 kDa matrix metalloproteinase (MMP-9) activity in exacerbations of asthma. Thorax 58, 757-760
147. Rasmussen, F., Taylor, D. R., Flannery, E. M. et al. (2002) Risk factors for hospital admission for asthma from childhood to young adulthood: a longitudinal population study. J. Allergy Clin. Immunol. 110, 220-227
148. Lange, P., Ulrik, C. S. and Vestbo, J. (1996) Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet 347, 1285-1289
149. Hansen, E. F., Phanareth, K., Laursen, L. C., Kok-Jensen, A. and Dirksen, A. (1999) Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 159, 1267-1271
150. Sont, J. K., Willems, L. N., Bel, E. H., van Krieken, J. H., Vandenbroucke, J. P. and Sterk, P. J. (1999) Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am. J. Respir. Crit. Care Med. 159, 1043-1051
151. Ward, C., Pais, M., Bish, R. et al. (2002) Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 57, 309-316
152. Boulet, L. P., Turcotte, H., Laviolette, M. et al. (2000) Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. Am. J. Respir. Crit. Care Med. 162, 1308-1313
153. Pauwels, R. A., Pedersen, S., Busse, W. W. et al. (2003) Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 361, 1071-1076
154. Haahtela, T., Jarvinen, M., Kava, T. et al. (1994) Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N. Engl. J. Med. 331, 700-705
155. Overbeek, S. E., Kerstjens, H. A., Bogaard, J. M., Mulder, P. G. and Postma, D. S. (1996) Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD)? The Dutch CNSLD Study Group. The Dutch Chronic Nonspecific Lung Disease Study Groups. Chest 110, 35-41